MENU
CYYNF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Cynata Therapeutics (CYYNF) Ownership - Who owns Cynata Therapeutics?
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus manufacturing platform... Show more
Profile
Industry
N/A
Address
100 Cubitt Street
Phone
+61 370676940
Employees
2
Web
https://www.cynata.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
34.4M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.27
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CYYNF
Capitalization
34.4M
P/E Ratio
N/A
Risk (Beta)
-0.27
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
7.11
Cash Flow
N/A
Earnings
-0.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-10.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-67.30
Shares Held By Institutions
2.68M
Shares Outstanding - Current
237M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
-37.895
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
100 Cubitt Street
Phone
+61 370676940
Employees
2
Web
https://www.cynata.com